Share on StockTwits
 

Investment analysts at Citigroup Inc. increased their target price on shares of Chemring Group (LON:CHG) from GBX 230 ($3.78) to GBX 260 ($4.27) in a note issued to investors on Friday, StockRatingsNetwork.com reports. The firm currently has a “neutral” rating on the stock. Citigroup Inc.’s price objective suggests a potential upside of 8.33% from the company’s current price.

CHG has been the subject of a number of other recent research reports. Analysts at Investec reiterated a “buy” rating on shares of Chemring Group in a research note to investors on Thursday. They now have a GBX 280 ($4.60) price target on the stock. Finally, analysts at Espirito Santo Investment Bank Research reiterated a “buy” rating on shares of Chemring Group in a research note to investors on Tuesday, November 26th. They now have a GBX 269 ($4.42) price target on the stock. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of GBX 257.11 ($4.22).

Shares of Chemring Group (LON:CHG) traded down 0.41% on Friday, hitting GBX 240.00. The stock had a trading volume of 576,482 shares. Chemring Group has a one year low of GBX 186.30 and a one year high of GBX 323.20. The stock has a 50-day moving average of GBX 221.9 and a 200-day moving average of GBX 259.. The company’s market cap is £463.9 million.

The company also recently announced a dividend, which is scheduled for Friday, May 9th. Shareholders of record on Wednesday, April 16th will be paid a dividend of GBX 3.80 ($0.06) per share. This represents a dividend yield of 1.57%. The ex-dividend date is Wednesday, April 16th.

Chemring Group PLC is engaged in the design, manufacture and sale of counter-improvised explosive device (LON:CHG) equipment, countermeasures, pyrotechnics and munitions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.